(NasdaqGM:USCB), MIAMI, July 03, 2025 (GLOBE NEWSWIRE) — USCB FINANCIAL HOLDINGS, INC. (the “Company”) (NASDAQ: USCB) will report financial results for the quarter ended June 30, 2025 after the market closes on Thursday, July 24, 2025. A conference call to discuss quarterly results will also be held with Chairman, President, and CEO, Luis de la […]

(NASDAQ:ORIC), SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on July 1, 2025 (the “Grant Date”), ORIC granted a total of 9,000 non-qualified stock options and 1,600 restricted

(NASDAQ:IRD), RESEARCH TRIANGLE PARK, N.C., July 03, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic disorders (the “Company”), today announced that, on June 30, 2025, it granted equity awards to two new

(NYSE:CODI), NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Compass Group Diversified Holdings, LLC (“Compass Diversified” or the “Company”) (NYSE: CODI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Compass Diversified investors who were adversely affected by alleged securities

(NYSE:VSTS), NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Vestis investors who were adversely affected by alleged securities fraud between May 2, 2024

USCB Financial Holdings, Inc. To Announce Second Quarter 2025 Results GlobeNewswire July 03, 2025 MIAMI, July 03, 2025 (GLOBE NEWSWIRE) — USCB FINANCIAL HOLDINGS, INC. (the “Company”) (NASDAQ: USCB) will report financial results for the quarter ended June 30, 2025 after the market closes on Thursday, July 24, 2025. A conference call to discuss quarterly

Investors who lost money on Compass Group Diversified Holdings, LLC (CODI) should contact Levi & Korsinsky about pending Class Action – CODI GlobeNewswire July 03, 2025 NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Compass Group Diversified Holdings, LLC (“Compass Diversified” or the “Company”) (NYSE: CODI) of a

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire July 03, 2025 SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on July 1, 2025 (the “Grant

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Vestis Corporation (VSTS) Shareholders GlobeNewswire July 03, 2025 NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit

Opus Genetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire July 03, 2025 RESEARCH TRIANGLE PARK, N.C., July 03, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic disorders (the “Company”), today